Drug Price Trends for NDC 23155-0486

Average Pharmacy Cost for 23155-0486

Drug Name	NDC	Price/Unit ($)	Unit	Date
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08362	EACH	2026-03-18
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08718	EACH	2026-02-18
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08834	EACH	2026-01-21
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08606	EACH	2025-12-17
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08535	EACH	2025-11-19
VERAPAMIL 120 MG TABLET	23155-0486-01	0.08279	EACH	2025-10-22
VERAPAMIL 120 MG TABLET	23155-0486-01	0.07913	EACH	2025-09-17

Best Wholesale Price for NDC 23155-0486

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Market Analysis and Price Projections for NDC 23155-0486

Last updated: February 23, 2026

What Is NDC 23155-0486?

NDC 23155-0486 corresponds to [Drug Name]. The drug is approved for [indications] and supplied by [manufacturer]. It has received FDA approval on [date] and is marketed primarily in [geographies].

Market Size and Sales Trends

Current Market Dynamics

• Estimated global market size (2022): $[value] billion
• US market share (2022): approximately [percentage]% of total sales
• Annual sales volume (2022): [units/amount in dollars]
• Growth rate (2021–2022): X%, driven by [key factors like increased adoption, expanded indications]

Key Competitors

Brand Name	Indication	Market Share	Price per unit	Launch Year
[Competitor A]	[Indication]	[X]%	$[amount]	[Year]
[Competitor B]	[Indication]	[Y]%	$[amount]	[Year]

Off-Label Uses and Expansion Opportunities

• Off-label use for [additional indications]
• Clinical trials ongoing for [new indications]
• Potential to expand in [geographical markets]

Regulatory Environment and Pricing Policies

Price Setting and Reimbursement

• Average wholesale price (AWP): $[amount] per unit
• Medicare/Medicaid reimbursement rates: [range or specific figures]
• Pricing trend (past 3 years): Increased by [X]% annually due to [pressures like inflation, formulary negotiations]

Price Comparisons with Similar Drugs

Drug Name	Price per Dose	Indications	Approval Year
[Drug X]	$[amount]	[Indication]	[Year]
[Drug Y]	$[amount]	[Indication]	[Year]

Price Regulation Trends

• Increasing emphasis on value-based pricing models
• Potential discounts due to biosimilar or generic competitors

Market Entry Barriers

• Patent protections until [year]
• High development costs for biosimilars or generics
• Regulatory requirements in emerging markets

Future Price Projections

Assumptions

• Annual sales growth rate: X% (based on historical data and pipeline potential)
• Patent expiration: [year]
• Introduction of biosimilars or generics: [estimated year]

Price Trajectory (2023–2028)

Year	Estimated Price per Unit	Factors Influencing Price
2023	$[amount]	Current price, stable regulatory environment
2024	$[amount]	Market expansion, new indications
2025	$[amount]	Entry of biosimilars, price competition
2026	$[amount]	Patent expiry, increased generic competition
2027	$[amount]	Market saturation, pricing discounts
2028	$[amount]	Expected biosimilar market penetration, further price erosion

Key Drivers of Price Decline

• Patent expiry timelines
• Entry of biosimilars or generics
• Increased payer pressure for discounted rates
• Regulatory reforms promoting price transparency

Key Takeaways

• NDC 23155-0486 holds a significant but potentially declining market position due to patent protection and upcoming biosimilar competition.
• Current average price per unit is $[amount], with projections indicating gradual decrease after patent expiry and biosimilar introduction.
• Market growth depends heavily on expanded indications and geographic penetration.
• Price regulation trends suggest a move towards value-based pricing models, impacting future revenue potential.

FAQs

1. What is the current market size for NDC 23155-0486?
   The global market size was approximately $[value] billion in 2022.

2. When is patent expiration expected?
   The patent is valid until [year], after which biosimilar competition is likely.

3. What are the main competitors?
   Key competitors include [Drug X], [Drug Y], with market shares of [X]% and [Y]% respectively.

4. How will biosimilar entry affect prices?
   Biosimilar entry typically results in price reductions of [estimated %] within 2–3 years post-launch.

5. What trends are influencing future price projections?
   Patent expiration, regulatory reforms, and the rise of biosimilars will impact prices, likely leading to a decline.

---

References

[1] U.S. Food and Drug Administration. (2022). Drugs@FDA: FDA-approved drugs.
[2] IQVIA. (2022). The IQVIA Healthcare Database.
[3] CMS.gov. (2022). Medicare reimbursement rate data.
[4] EvaluatePharma. (2022). Global pharmaceutical market forecasts.